
(Credit: PHOTOCREO Michal Bednarek/Shutterstock)
Stealth Livestock Virus Replicates In Human Tissue, Evades Immune Detection
In A Nutshell
- Silent infections happening now: Influenza D virus has been detected in farm workers and shows up in antibody tests, suggesting human infections that cause few or no symptoms
- Human tissue welcomes the virus: Laboratory tests show the virus replicates efficiently in human lung cells, airway cultures, and lung tissue with minimal immune resistance
- Stealth strategy enables spread: The virus suppresses early immune alarms, allowing it to establish infection before the body mounts defenses: potentially enabling undetected transmission
- Animal studies show easy transmission: Contact and airborne spread documented in ferrets and other mammals, with the virus infecting multiple species while causing minimal symptoms
Most people have never heard of influenza D virus, and there’s a good reason for that. Since its discovery in 2011, this flu strain has stuck to cattle and pigs, staying off the human health radar. But a new preprint study suggests it may have been quietly slipping into human populations all along.
Genetic traces of the virus have been detected in hospital air and airport aerosol samples by other research teams, and viral material has been found in nasal swabs from farm workers. Unlike regular flu, these infections don’t seem to make people noticeably sick. That might sound like good news, but scientists say it’s actually the opposite. A virus that spreads without symptoms is a virus that spreads undetected.
Laboratory studies from The Ohio State University reveal why this stealth approach works so well. When researchers tested flu D in human lung tissue, they found it replicates just as efficiently as seasonal flu while barely triggering immune alarms. It’s like a burglar who knows exactly how to avoid setting off the security system.
Detected in Hospital and Airport Air by Other Studies
Environmental sampling by other research teams has picked up genetic traces of flu D in aerosol samples from both a hospital emergency room and a busy airport. If that doesn’t grab your attention, it should. These are exactly the kinds of places where a future pandemic virus might first gain a foothold in human populations.
Hospital air contamination is particularly worrying because it suggests the virus could spread among vulnerable patients. Airport detection raises the possibility of transmission during travel, when people from different regions mix in confined spaces for hours at a time.
The environmental findings match up with direct evidence of human infection. Previous research has confirmed viral genetic material in nasal washes from a swine worker, strongly suggesting the virus can infect people. Surveillance studies consistently find influenza D antibodies in cattle workers and pig handlers, indicating that exposure and infection happen more often than anyone realized.

Silent Spread Is the Real Danger
Regular flu viruses announce themselves with fever, aches, and that unmistakable feeling of being hit by a truck. Influenza D takes a different approach. Documented human infections so far appear mild or symptom-free, raising concerns that cases could go unnoticed.
Laboratory experiments explain the pattern. When the research team infected human respiratory cells with various flu D strains, they found the virus had essentially learned to fly under the radar. It suppresses the cellular alarm systems that normally alert the immune system to viral invasion, allowing it to establish infection and start replicating before defenses kick in.
This creates a perfect storm for pandemic potential. People with subclinical infections feel fine, so they could go about their normal routines while potentially spreading virus to others. Public health surveillance systems built to catch symptomatic cases would miss these infections entirely.
Human Lungs Welcome the Virus
Laboratory testing revealed that human respiratory tissue puts up surprisingly little resistance to influenza D infection. The research team tried three different approaches: immortalized lung cells, airway cultures grown from donor tissue, and precision-cut lung slices that preserve the complex structure of respiratory organs. In every test, the virus replicated to high levels.
Cross-species comparisons told an even more concerning story. Infection patterns looked remarkably similar whether the virus was growing in human, pig, or cattle tissue. This compatibility suggests influenza D already has most of the tools it needs for efficient human infection.
The virus can latch onto cell surface receptors that are abundant in human nose and lungs, giving it plenty of entry points. While it initially replicates a bit slower in human tissue compared to pig tissue, it ultimately reaches the same high levels.
Limited Changes May Be Needed for Human Spread
In animal studies, including ferrets, both contact and airborne transmission have been documented. The virus spreads in multiple species despite causing little or no obvious illness.
The fact that most animals show no symptoms while harboring replicating virus should set off alarm bells. It suggests flu D has already evolved the ability to establish subclinical infections across mammalian species. Only cattle consistently develop respiratory symptoms.
Between 2017 and 2020, researchers collected samples from more than 24,000 pigs at livestock exhibitions across 13 states, identifying active circulation of multiple influenza D strains in venues where animals and humans interact closely. The surveillance identified several new strains that had never been seen before.
While flu D can’t swap genes with seasonal flu viruses, previous research has shown its two major lineages can exchange genetic material with each other. This reshuffling process could produce variants better adapted to human hosts.
Why Stealth Viruses Pose Greater Threats
Highly pathogenic bird flu strains often kill their hosts through overwhelming inflammation. That’s terrible for the individuals affected, but it also limits spread because severely ill people don’t travel around infecting others. Flu D’s subtle approach may be more dangerous in the long run.
Laboratory experiments showed that once human cells were put on high alert with interferon treatments, the virus became highly vulnerable to antiviral defenses. This suggests it has evolved sophisticated methods to avoid initial detection rather than to resist immune responses once they’re activated.
With continued circulation in livestock and repeated spillover into humans, the virus has plenty of opportunities to acquire mutations that could boost transmissibility or cause more severe disease. The researchers emphasized that their work elevates influenza D from an obscure livestock pathogen to “a legitimate pandemic threat requiring immediate surveillance.”
What looks like a harmless farm animal virus today may already be taking the evolutionary steps needed to become tomorrow’s human pandemic. Enhanced monitoring at places where animals and people interact will be critical for spotting those changes before they spread too far.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. The research discussed involves laboratory studies and does not establish confirmed human-to-human transmission of influenza D virus. Consult healthcare professionals for medical guidance regarding respiratory infections or exposure to livestock.
Paper Notes
Limitations
This research used laboratory models rather than clinical studies in humans. While the team employed multiple realistic systems including primary human airway cultures and precision-cut lung tissue, these may not fully capture how the virus behaves in living people. The study examined six viral strains from U.S. surveillance, which may not represent global influenza D diversity. Long-term infection outcomes and human-to-human transmission patterns remain unknown.
Funding and Disclosures
Research was supported by the United States Department of Agriculture National Institute of Food and Agriculture under contract 2025-39601-44639 and an intramural grant from The Enterprise for Research, Innovation, and Knowledge at The Ohio State University. Additional funding came from the Centers of Excellence for Influenza Research and Response, National Institute of Allergy and Infectious Diseases, National Institutes of Health, under contracts HHSN272201400006C and 75N93021C00016. Authors reported no competing financial interests.
Publication Details
Study authors include Christina G. Sanders, Min Liu, Jovanna A. Fusco, Elizabeth M. Ohl, Natalie N. Tarbuck, Emily M. King, Devra Huey, Thomas P. Fabrizio, Phylip Chen, Amanda R. Panfil, Richard J. Webby, Mark E. Peeples, Andrew S. Bowman, and Cody J. Warren from The Ohio State University, St. Jude Children’s Research Hospital, and Nationwide Children’s Hospital. Published as preprint on bioRxiv February 8, 2026. DOI: https://doi.org/10.64898/2026.02.07.704474. Corresponding author: Cody J. Warren ([email protected]).







